Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Genfit

Clinical trials sponsored by Genfit, explained in plain language.

Genfit GNFT EURONEXT PARIS

A biopharmaceutical company developing treatments for liver diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1 Completed 1 Terminated 2

Experimental drug aims to halt liver failure in cirrhosis patients

Disease control Not yet recruiting

This study tests whether adding the drug NTZ to standard care can help people with liver cirrhosis who experience a sudden worsening (acute decompensation) or have developed acute-on-chronic liver failure. The trial enrolls adults with cirrhosis from any cause who have had a rece…

Phase: PHASE2 • Sponsor: Genfit • Aim: Disease control

Last updated Jul 11, 2026 00:00 UTC